image
PDS Biotechnology Corporation PDSB
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.01
-10.7 %
$ 74 M
Market Cap
-1.63
P/E
BALANCE SHEET
59.4 M ASSETS
-22.88%
Growth Rates
1Year -22.88%
3Years 24.35%
5Years 10.40%
7Years -8.54%
10Years 21.13%
33.3 M LIABILITIES
0.77%
Growth Rates
1Year 0.77%
3Years 106.80%
5Years 39.12%
7Years 6.33%
10Years 3.28%
26.1 M EQUITY
-40.61%
Growth Rates
1Year -40.61%
3Years -1.24%
5Years -2.62%
7Years -16.10%
10Years 13.99%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition PDS Biotechnology Corporation
image
Current Assets 59.1 M
Cash & Short-Term Investments 56.6 M
Receivables 0
Other Current Assets 2.49 M
Non-Current Assets 335 K
Long-Term Investments 0
PP&E 335 K
Other Non-Current Assets 0
Current Liabilities 13.6 M
Accounts Payable 6.98 M
Short-Term Debt 4.22 M
Other Current Liabilities 2.42 M
Non-Current Liabilities 19.6 M
Long-Term Debt 19.6 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
ASSETS
Cash & Cash Equivalents 56.6 73.8 65.2 28.8 12.2 34.6 88.1 106.4 130.2 13.7 7.9
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0
Receivables 0 0 0 0 0 0 0 0 0 0 0.5
Inventory 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 2.5 2.7 1.6 1.5 2.3 1.0 50.9 K 0.1 1.1 1.6 0.2
Total Current Assets 59.1 76.5 66.8 30.3 14.5 35.7 89.1 107.4 131.3 15.4 8.5
PP&E 0.3 0.5 0.4 0.6 21.1 K 0.4 3.4 3.4 2.8 1.4 0.1
Intangible Assets 0 0 0 0 0 0 46.8 K 51.9 K 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 0 0 0 0 0.1 96.1 K 91 K 55.2 K 0.2 63.9 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0
Total Assets 59.4 77.0 67.2 30.9 14.5 36.2 92.6 110.9 134.1 17.0 8.7
LIABILITIES
Accounts Payable 7.0 1.2 1.3 1.4 1.2 0.4 4.4 3.5 2.6 2.0 1.1
Short Term Debt 4.2 0.3 0.3 0.1 0 0 3.1 0 (0.3) 0.3 0
Other Current Liabilities 2.4 8.3 2.2 1.7 1.6 6.0 5.4 3.2 3.7 1.6 0.7
Total Current Liabilities 13.6 9.8 3.8 3.3 2.8 6.4 12.9 6.7 8.6 3.9 1.8
Long Term Debt 19.6 23.2 0.2 0.5 0 30 K 17.4 15.0 3.0 2.5 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0.3 0 0 0 38.5 22.3
Total Liabilities 33.3 33.0 4.0 3.8 2.8 6.4 30.2 21.6 11.6 44.9 24.1
EQUITY
Common Stock 10.9 K 9.96 K 9.39 K 7.35 K 1.74 K 10.6 K 10.4 K 9.76 K 9.72 K 770 770
Retained Earnings (144.5) (101.6) (60.7) (43.8) (28.9) (192.8) (151.9) (101.1) (62.3) (29.8) (16.0)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 (0.5) (0.3) (0.1) 91.4 K 38.3 K 7.05 K
Total Equity 26.1 44.0 63.2 27.1 11.7 29.8 62.4 89.3 122.5 (27.8) (15.3)
Total Liabilities and Equity 59.4 77.0 67.2 30.9 14.5 36.2 92.6 110.9 134.1 17.0 8.7
SHARES OUTSTANDING
Common Shares Outstanding 31.0 28.6 25.6 16.7 4.9 1.6 1.5 1.4 0.4 0.8 0.8